Endothelial glycocalyx degradation during sepsis: Causes and consequences

Matrix Biol Plus. 2021 Nov 27:12:100094. doi: 10.1016/j.mbplus.2021.100094. eCollection 2021 Dec.

Abstract

The glycocalyx is a ubiquitous structure found on endothelial cells that extends into the vascular lumen. It is enriched in proteoglycans, which are proteins attached to the glycosaminoglycans heparan sulfate, chondroitin sulfate, dermatan sulfate, keratan sulfate, and hyaluronic acid. In health and disease, the endothelial glycocalyx is a central regulator of vascular permeability, inflammation, coagulation, and circulatory tonicity. During sepsis, a life-threatening syndrome seen commonly in hospitalized patients, the endothelial glycocalyx is degraded, significantly contributing to its many clinical manifestations. In this review we discuss the intrinsically linked mechanisms responsible for septic endothelial glycocalyx destruction: glycosaminoglycan degradation and proteoglycan cleavage. We then examine the consequences of local endothelial glycocalyx loss to several organ systems and the systemic consequences of shed glycocalyx constituents. Last, we explore clinically relevant non-modifiable and modifiable factors that exacerbate or protect against endothelial glycocalyx shedding during sepsis.

Keywords: ADAM, A Disintegrin and Metalloproteinase; ANP, Atrial Natriuretic Peptide; ARDS, Acute respiratory distress syndrome; Ang2, Angiopoietin-2; DAMP, Damage-associated Molecular Pattern; Endothelial glycocalyx; FFP, Fresh Frozen Plasma; GAG, Glycosaminoglycan; Glycosaminoglycans; HPSE-1/2, Heparanase-1/2; LPS, Lipopolysaccharide; MMP, Matrix Metalloproteinase; PG, Proteoglycan; Proteoglycans; Sepsis; TIMP, Tissue inhibitors of matrix metalloproteinase.